Evidence map›Paper›PMID 36585374›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2023

Aqueous Two-Phase Enabled Low Viscosity 3D (LoV3D) Bioprinting of Living Matter.

Malin Becker, Melvin Gurian, Maik Schot, Jeroen Leijten

Full text read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Aqueous Two-Phase Enabled Low Viscosity 3D (LoV3D) Bioprinting of Living Matter.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Malin BeckerLeijten Lab, Dept. of Developmental BioEngineering, TechMed Centre, University of Twente, Enschede, 7522 NB, The Netherlands.ORCID 0000-0002-5294-9715
Melvin GurianLeijten Lab, Dept. of Developmental BioEngineering, TechMed Centre, University of Twente, Enschede, 7522 NB, The Netherlands.ORCID 0000-0001-5522-3875
Maik SchotLeijten Lab, Dept. of Developmental BioEngineering, TechMed Centre, University of Twente, Enschede, 7522 NB, The Netherlands.ORCID 0000-0001-6090-8000
Jeroen LeijtenLeijten Lab, Dept. of Developmental BioEngineering, TechMed Centre, University of Twente, Enschede, 7522 NB, The Netherlands.ORCID 0000-0002-8063-207X

Funding

Dutch Research Council 17522European Research Council 759425
6 · The paper itself

Abstract

Embedded 3D bioprinting has great value for the freeform fabrication of living matter. However, embedded 3D bioprinting is currently limited to highly viscous liquid baths or liquid-like solid baths. In contrast, prior to crosslinking, most hydrogels are formulated as low-viscosity solutions and are therefore not directly compatible with bioprinting due to low shape fidelity and poor print stability. The authors here present a method to enable low-viscosity ink 3D (LoV3D) bioprinting, based on aqueous two-phase stabilization of the ink-bath interface. LoV3D allows for the printing of living constructs at high extrusion speeds (up to 1.8 m s

Indexed as

BioprintingHydrogelsPrinting, Three-DimensionalRheologyViscosityHydrogelsbiofabricationbiofunctionalizationembedded bioprintingtissue engineeringvascularization

Identifiers

PMID36585374
PMCPMC10015849

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read145
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.